A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer

This study is to investigate the efficacy of Targeted Microwave Ablation (TMA) under MRI-Ultrasound fusion and organ-based tracking (OBT) navigation in localized prostate cancer (PCa) in a multi-centre trial.

Trial Details

NCT ID
NCT06262633
Phase
NA
Sponsor
Chinese University of Hong Kong
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Targeted Microwave Ablation (TMA) for localized prostate cancer using organ based tracking (OBT) navigation
Locations (sample)
  • Shatin, Hong Kong|22.38333,114.18333

Key Eligibility Criteria

  • Men aged between 45 - 75 years
  • Life expectancy \> 10 years upon recruitment
  • Able to understand the trial and can provide informed and written consent, dated and signed before the enrollment and before any exam required by t…
  • Localized low or intermediate risk prostate cancer diagnosed on MRI-Ultrasound fusion targeted biopsy

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →